Nocathiacin III

Nocathiacin III (Nocathiacine III) is highly resistant to Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP) and multidrug resistant Enterococcus faecalis (MREF) [1].

Product Specifications

CAS Number

[256230-47-4]

Product Name Alternative

Nocathiacine III

UNSPSC

12352005

Target

Bacterial

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

ON1C2=CC=CC3=C2C4=C1C(OC[C@@]5([H])C6=NC(C7=NC(C8=NC(C(NC(C(N)=O)=C)=O)=CS8)=C(O)C=C7C9=NC(C(N[C@@](C(N/C(C%10=NC(C(N[C@@](C%11=NC(C(N5)=O)=CS%11)([H])[C@]([C@@H](C(OC3)=O)O)([H])OC4)=O)=CS%10)=C(C)/OC)=O)([H])[C@H](O)C)=O)=CS9)=CS6)=O

Molecular Formula

C52H43N13O16S5

Molecular Weight

1266.30

References & Citations

[1]Sheo B Singh, et al. Nocathiacin, Thiazomycin, and Polar Analogs Are Highly Effective Agents against Toxigenic Clostridioides difficile. J Nat Prod. 2022 Apr 22;85 (4) :1141-1146.